Wensi Zhao
- Topics
- Esophageal Cancer Research and Treatment (8 papers)Cancer Immunotherapy and Biomarkers (7 papers)Analytical Chemistry and Chromatography (5 papers)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Wensi Zhao
36 papers receiving 377 citations
Peers
Comparison fields: 5 of 88
- Molecular Biology 145
- Oncology 115
- Pulmonary and Respiratory Medicine 63
- Surgery 61
- Spectroscopy 47
Countries citing papers authored by Wensi Zhao
This map shows the geographic impact of Wensi Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wensi Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wensi Zhao more than expected).
Fields of papers citing papers by Wensi Zhao
This network shows the impact of papers produced by Wensi Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wensi Zhao. The network helps show where Wensi Zhao may publish in the future.
Co-authorship network of co-authors of Wensi Zhao
This figure shows the co-authorship network connecting the top 25 collaborators of Wensi Zhao. A scholar is included among the top collaborators of Wensi Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wensi Zhao. Wensi Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 5 | |
| 6 | 3 | |
| 7 | 2 | |
| 8 | 1 | |
| 9 | 12 | |
| 10 | 18 | |
| 11 | 18 | |
| 12 | 66 | |
| 13 | 1 | |
| 14 | 10 | |
| 15 | 7 | |
| 16 | 4 | |
| 17 | 7 | |
| 18 | 16 | |
| 19 | Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma. | 24 |
| 20 | 14 |
About Wensi Zhao
Wensi Zhao is a scholar working on Oncology, Spectroscopy and Analytical Chemistry, having authored 38 papers that have together received 380 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Analytical Chemistry and Chromatography (5 papers). The work is most often cited by research in Oncology (115 citations), Analytical Chemistry (40 citations) and Cancer Research (47 citations). Wensi Zhao has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Hu Qiu, Junbo Liu, Ruifa Jin, Shanshan Tang, Shaobo Ke, Minjia Tan, Mengdi Zhu, Hao Hu, Jun‐Yu Xu and Linhui Zhai. Their work appears in journals such as Journal of Clinical Oncology, Analytical Chemistry and Journal of Hazardous Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.